InvestorsHub Logo
Post# of 180287
Next 10
Followers 23
Posts 4476
Boards Moderated 0
Alias Born 07/15/2012

Re: None

Friday, 01/19/2024 1:36:58 PM

Friday, January 19, 2024 1:36:58 PM

Post# of 180287
Vivos Inc. is a late stage development company engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos is focused on transitioning to full commercial operations anticipating receipt of an approved FDA Investigational Device Exemption (IDE) clearance for its multi patented next-generation brachytherapy cancer product, yttrium-90 RadioGel™
( Michael Korenko, Sc.D. President & CEO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News